Today’s Solutions: October 20, 2026

Since 2000, malaria mortality rates have fallen by 66% among all ages groups and by 71% among children under five in Africa. The massive drop is a testament to the hard work of malaria prevention workers, but there is still much work to be done to rid the world of the disease. A new vaccine developed by a U.S-based team could do just that. The vaccine uses a genetically modified version of the parasite that exposes the immune system to the disease without allowing it to develop into full-blown malaria. In initial tests, the vaccine stimulated a response that could block an actual infection without any significant side-effects. The results are promising and has warranted further clinical testing.

Solutions News Source Print this article
More of Today's Solutions

World’s tallest wind turbine reaches 1,197 feet in Germany

BY THE OPTIMIST DAILY EDITORIAL TEAM The world's tallest wind turbine just reached full height in Germany. GICON's pilot turbine in Schipkau, eastern Germany, ...

Read More

Fall nostalgia: why your nervous system reaches for reruns when autumn arrives

BY THE OPTIMIST DAILY EDITORIAL TEAM Every fall, something happens in the body before it happens in the mind. The smell of wood smoke ...

Read More

Beekeepers and airports join forces to save pollinators

Back in 2012, Ben Shertzer, wildlife administrator at Pittsburgh International Airport, found himself dealing with a perplexing problem: swarming bees. The bees would land ...

Read More

Scotland lays out new road map to reach net zero by 2045

BY THE OPTIMIST DAILY EDITORIAL TEAM Scotland took its next step toward reaching net-zero greenhouse gas emissions by 2045, releasing a sweeping draft climate ...

Read More